Atlas Trials

Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment

Clinical trial NCT06086587 · UNKNOWN

Trial details

NCT number
NCT06086587
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung Cancer
Start date
2023-11-07
Primary completion
2024-10-31
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.